Genetic screening for Peutz-Jeghers syndrome

Expert Review of Molecular Diagnostics

Volumn 3, Issue 4, 2003, Pages 471-479

  Ballhausen, Wolfgang G ^a   Günther, Klaus ^b  

^a MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

^b UNIVERSITY OF REGENSBURG   (Germany)

Author keywords

Gene regulation; Germline; Heterogeneity; Intestinal hamartomatous polyposis; Mutation; Nonsense mediated mRNA decay; Peurz Jeghers syndrome; Protein in vitro synthesis; Screening; STK11; Tumor predisposing syndrome

Indexed keywords

GENE PRODUCT; PROTEIN SERINE THREONINE KINASE;

ALLELISM; CANCER GENETICS; CANCER RISK; CANCER SCREENING; CLINICAL FEATURE; GENE MUTATION; GENETIC HETEROGENEITY; GENETIC SCREENING; HUMAN; LKB1 GENE; ONCOGENE; PEUTZ JEGHERS SYNDROME; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; STK11 GENE;

EID: 0038159916     PISSN: 14737159     EISSN: None     Source Type: Journal    
DOI: 10.1586/14737159.3.4.471     Document Type: Review

References (52)

1. Tomlinson IPM, Houlston RS. Peutz-Jeghers syndrome. J. Med. Genet. 34(12), 1007-1011 (1997).
2. Yoo LI, Chung DC, Yuan J. LKB1: a master tumour suppressor of the small intestine and beyond. Nature Rev. Cancer 2(7), 529-535 (2002). Excellent review of molecular genetics and cell biology of the serine/threonine kinase (STK11) gene.
3. McGarrity TJ, Kulin HE, Zaino RJ. Peutz-Jeghers syndrome. Am. J. Gastroenterol. 95(3), 596-604 (2000). Nice review of clinical aspects of Peutz-Jeghers syndrome (PJS).
4. Semelka RC, Marcos HB. Polyposis syndromes of the gastrointestinal tract: MR findings. J. Magn. Reson. Imaging 11(1), 51-55 (2000).
5. Scapa E, Jacob H, Lewkowicz S et al. Initial experience of wireless-capsule endoscopy for evaluating occult gastrointestinal bleeding and suspected small bowel pathology. Am. J. Gastroenterol. 97(11), 2776-2779 (2002). Practical relevance of this new technology for endoscopic surveillance.
6. Edwards DP, Khosraviani K, Stafferton A et al. Long-term results of polyp clearance by intraoperative enteroscopy in the Peutz-Jeghers syndrome. Dis. Colon Rectum 46(1), 48-50 (2003).
7. Giardiello FM, Brensinger JD, Tersmette AC et al. Very high risk of cancer in familial Peutz-Jeghers syndrome. Gastroenterology 119(6), 1447-1453 (2000). Meta-analysis of cancer risk in PJS.
8. Dunlop MG. Guidance on gastrointestinal surveillance for hereditary non-polyposis colorectal cancer, familial adenomatous polyposis, juvenile polyposis and Peutz-Jeghers syndrome. Gut 51(Suppl. 5), V21-V27 (2002).
9. Spigelman AD, Arese P, Phillips RK. Polyposis: the Peutz-Jeghers syndrome. Br. J. Surg. 82(10), 1311-1314 (1995).
10. Hemminki A, Markie D, Tomlinson I et al. A serine/threonine kinase gene defective in Peutz-Jeghers syndrome. Nature 391(6663), 184-187 (1998). First identification of STK11 being the PJS gene.
11. Jenne DE, Reimann H, Nezu J et al. Peutz-Jeghers syndrome is caused by mutations in a novel serine threonine kinase. Nature Genet. 18(1), 38-43 (1998).
12. Su JY, Erikson E, Maller JL. Cloning and characterization of a novel serine/threonine protein kinase expressed in early Xenopus embryos. J. Biol. Chem. 271(24), 14430-14437 (1996).
13. Watts JL, Morton DG, Bestman J, Kemphues KJ. The C elegans par-4 gene encodes a putative serine-threonine kinase required for establishing embryonic asymmetry. Development 127(7), 1467-1475 (2000).
14. Martin SG, St Johnston D. A role for Drosophila LKB1 in anterior-posterior axis formation and epithelial polarity. Nature 421(6921), 379-384 (2003).
15. Ylikorkala A, Rossi DJ, Korsisaari N et al. Vascular abnormalities and deregulation of VEGF in Lkb1-deficient mice. Science 293(5533), 1323-1326 (2001).
16. Bardeesy N, Sinha M, Hezel AF et al. Loss of the Lkb1 tumour suppressor provokes intestinal polyposis but resistance to transformation. Nature 419(6903), 162-167 (2002). Yields major insights into the tumor biology of neoplasia in a PJS mouse model.
17. Jishage K, Nezu J, Kawase Y et al. Role of Lkb1, the causative gene of Peutz-Jegher's syndrome, in embryogenesis and polyposis. Proc. Natl. Acad. Sci. USA 99(13), 8903-8908 (2002).
18. Miyoshi H, Nakau M, Ishikawa TO, Seldin MF, Oshima M, Taketo MM. Gastrointestinal hamartomatous polyposis in Lkb1 heterozygous knockout mice. Cancer Res. 62(8), 2261-2266 (2002).
19. Rossi DJ, Ylikorkala A, Korsisaari N et al. Induction of cyclooxygenase-2 in a mouse model of Peutz-Jeghers polyposis. Proc. Natl. Acad. Sci. USA 99(19), 12327-12332 (2002). In vivo data on cyclo-oxygenase-2 production in PJS mouse model. Implications for treatment of PJS patients.
20. Abed AA, Gunther K, Kraus C, Hohenberger W, Ballhausen WG. Mutation screening at the RNA level of the STK11/LKB1 gene in Peutz-Jeghers syndrome reveals complex splicing abnormalities and a novel mRNA isoform (STK11 c.597 598insIVS4). Hum. Mutat. 18(5), 397-410 (2001).
21. Luukko K, Ylikorkala A, Tiainen M, Makela TP. Expression of LKB1 and PTEN tumor suppressor genes during mouse embryonic development. Mech. Dev. 83(1-2), 187-190 (1999).
22. Rowan A, Churchman M, Jefferey R, Hanby A, Poulsom R, Tomlinson I. In situ analysis of LKB1/STK11 mRNA expression in human normal tissues and tumours. J. Pathol. 192(2), 203-206 (2000).
23. Collins SP, Reoma JL, Gamm DM, Uhler MD. LKB1, a novel serine/threonine protein kinase and potential tumour suppressor, is phosphorylated by cAMP-dependent protein kinase (PKA) and prenylated in vivo. Biochem. J. 345(3), 673-680 (2000).
24. Sapkota GP, Kieloch A, Lizcano JM et al. Phosphorylation of the protein kinase mutated in Peutz-Jeghers cancer syndrome, LKB1/STK11, at SeR431 by p90(RSK) and cAMP-dependent protein kinase but not its farnesylation at Cys(433) is essential for LKB1 to suppress cell growth. J. Biol. Chem. 276(22), 19469-19482 (2001). Demonstration of STK11 protein being extensively modified at the post-translational level.
25. Sapkota GP, Deak M, Kieloch A et al. Ionizing radiation induces ataxia telangiectasia mutated kinase (ATM)-mediated phosphorylation of LKB1/STK11 at Thr-366. Biochem. J. 368(2), 507-516 (2002). Involvement of STK11 in DNA repair.
26. Ylikorkala A, Avizienyte E, Tomlinson IP et al. Mutations and impaired function of LKB1 in familial and non-familial Peutz-Jeghers syndrome and a sporadic testicular cancer. Hum. Mol. Genet. 8(1), 45-51 (1999).
27. Nezu J, Oku A, Shimane M. Loss of cytoplasmic retention ability of mutant LKB1 found in Peutz-Jeghers syndrome patients. Biochem. Biophys. Res. Commun. 261(3), 750-755 (1999).
28. Smith DP, Spicer J, Smith A, Swift S, Ashworth A. The mouse Peutz-Jeghers syndrome gene Lkb1 encodes a nuclear protein kinase. Hum. Mol. Genet. 8(8), 1479-1485 (1999).
29. Karuman P, Gozani O, Odze RD et al. The Peutz-Jegher gene product LKB1 is a mediator of p53-dependent cell death. Mol. Cell 7(6), 1307-1319 (2001). First demonstration that STK11 participates in p53-dependent apoptosis.
30. Tiainen M, Vaahtomeri K, Ylikorkala A, Makela TE. Growth arrest by the LKB1 tumor suppressor: induction of p21(WAF1/CIP1). Hum. Mol. Genet. 11(13), 1497-1504 (2002).
31. Smith DP, Rayter SI, Niederlander C, Spicer J, Jones CM, Ashworth A. LIP1, a cytoplasmic protein functionally linked to the Peutz-Jeghers syndrome kinase LKB1. Hum. Mol. Genet. 10(25), 2869-2877 (2001).
32. Marignani PA, Kanai F, Carpenter CL. LKB1 associates with Brg1 and is necessary for Brg1-induced growth arrest. J. Biol. Chem. 276(35), 32415-32418 (2001). Demonstration of STK11 being associated with chromatin remodelling molecules.
33. Boudeau J, Deak M, Lawlor MA, Morrice NA, Alessi DR. Hsp90/Cdc37 interact with LKB1 and regulate its stability. Biochem. J. 370(3), 849-857 (2003).
34. Wang Z-J, Churchman M, Avizienyte E et al. Germline mutations of the LKB1 STK11) gene in Peutz-Jeghers patients. J. Med Genet. 36(5), 365-368 (1999).
35. Mehenni H, Gehrig C, Nezu J et al. Loss of LKB1 kinase activity in Peutz-Jeghers syndrome and evidence for allelic and locus heterogeneity. Am. J. Hum. Genet. 63(6), 1641-1650 (1998).
36. Bernard M, Sanseau P, Henry C, Couturier A, Prigent C. Cloning of STK13, a third human protein kinase related to Drosophila aurora and budding yeast Ipl1 that maps on chromosome 19q13.3-ter. Genomics 53(3), 406-409 (1998).
37. Jiang CY, Esufali S, Berk T et al. STK11/LKB1 germline mutations are not identified in most Peutz-Jeghers syndrome patients. Clin. Genet 56(2), 136-141 (1999).
38. Boardman LA, Couch FJ, Burgart LJ et al. Genetic heterogeneity in Peutz-Jeghers syndrome. Hum. Mutat. 16(1), 23-30 (2000).
39. Buchet-Poyau K, Mehenni H, Radhakrishna U, Antonarakis SE. Search for the second Peutz-Jeghers syndrome locus: exclusion of the STK13, PRKCG, KLK10 and PSCD2 genes on chromosome 19 and the STK11IP gene on chromosome 2. Cytogenet. Genome Res. 97(3-4), 171-178 (2002).
40. Nakagawa H, Koyama K, Miyoshi Y et al. Nine novel germline mutations of STK11 in ten families with Peutz-Jeghers syndrome. Hum. Genet. 103(2), 168-172 (1998).
41. Westerman AM, Entius MM, Boor PPC et al. Novel mutations in the LKB1/STK11 gene in Dutch Peutz-Jeghers families. Hum. Mutat. 13(6), 476-481 (1999).
42. Scott RJ, Crooks R, Meldrum CJ et al. Mutation analysis of the STK11/LKB1 gene and clinical characteristics of an Australian series of Peutz-Jeghers syndrome patients. Clin. Genet. 62(4), 282-287 (2002).
43. Jordanova A, Kalaydjieva L, Savov A et al. SSCP analysis: a blind sensitivity trial. Hum. Mutat. 10(1), 65-70 (1997).
44. Holinski-Feder E, Muller-Koch Y, Friedl W et al. DHPLC mutation analysis of the hereditary non-polyposis colon cancer (HNPCC) genes hMLH1 and hMSH2. Biochem. Biophys. Methods 47(1-2), 21-32 (2001).
45. Park WS, Moon YW, Yang YM et al. Mutations of the STK11 gene in sporadic gastric carcinoma. Int. J. Oncol. 13(3), 601-604 (1998).
46. Martinez LA, Naguibneva I, Lehrmann H et al. Synthetic small inhibiting RNAs: efficient tools to inactivate oncogenic mutations and restore p53 pathways. Proc. Natl. Acad. Sci. USA 99(23), 14849-14854 (2002). Application of small interference RNA for the elimination of aberrant transcripts.
47. Esteller M, Avizienyte E, Corn PG et al. Epigenetic inactivation of LKB1 in primary tumors associated with the Peutz-Jeghers syndrome. Oncogene 19(1), 164-168 (2000). Functional inactivation of STK11 by promoter methylation.
48. Trojan J, Brieger A, Raedle J, Esteller M, Zeuzem S. 5′-CpG island methylation of the LKB1/STK11 promoter and allelic loss at chromosome 19p13.3 in sporadic colorectal cancer. Gut 47(2), 272-276 (2000).
49. Kraus C, Braun-Quentin C, Ballhausen WG, Pfeiffer RA. RNA-based mutation screening in German families with Sjogren-Larsson syndrome. Eur. J. Hum. Genet. 8(4), 299-306 (2000).
50. Andreutti-Zaugg C, Scott RJ, Iggo R. Inhibition of nonsense-mediated messenger RNA decay in clinical samples facilitates detection of human MSH2 mutations with an in vivo fusion protein assay and conventional techniques. Cancer Res. 57(15), 3288-3293 (1997).
51. Sun X, Perlick HA, Dietz HC, Maquat LE. A mutated human homologue to yeast Upfl protein has a dominant-negative effect on the decay of nonsense-containing RNAs in mammalian cells. Proc. Natl. Acad. Sci. USA 95(17), 10009-10014 (1998).
52. Frischmeyer PA, Dietz HC. Nonsense-mediated mRNA decay in health and disease. Hum. Mol. Genet. 8(10), 1893-1900 (1999).